Inflammation-reducing drug shows no benefit for dry age-related macular degeneration in NIH trial

Dry AMD affects part of the eye’s retina that allows for clear central vision.

Antioxidants, Free Full-Text

A deeper look at pegcetacoplan

A deeper look at pegcetacoplan

Aviceda begins part 2 of Phase II/III trial for geographic atrophy

News & Events National Institutes of Health (NIH)

Age-related Macular Degeneration Diagnosis and Treatment.pdf

MACULAR DEGENERATION: THE RETINA INSTITUTE BOARD CERTIFIED RETINAL

NIH Science in Seconds - Week of March 18, 2024

Introduction to biosimilars for AMD

Media Resources Clinical Center Home Page

News and Events National Eye Institute

Immunology of age-related macular degeneration

Age-Related Macular Degeneration - Fighting Blindness Canada (FBC)